Tag: clinical trials

Stories

Is P < .05 Good Enough?

90 plus years ago, the book Statistical Methods for Research Workers established the P< .05 concept as a gold standard. But is it really a good benchmark?

Read More

Canadian IPF Drug, PBI-4050, Continues to Show Promise

Canadian pharmaceutical company, Prometic Life Sciences, announced the latest data from their lead candidate, PBI-4050, to treat idiopathic pulmonary fibrosis (IPF), presented at the American Thoracic Society (ATS) 2018 International Conference being held in San Diego, California.

Read More

Alström Syndrome Clinical Trial Showing Promise

Canadian pharmaceutical company, Prometic Life Sciences Inc provided an update on their ongoing Phase 2 clinical trial involving the use of PBI-4500 to treat patients with Alström syndrome. Alström syndrome is a rare genetic condition due to mutations in the ALMS1 gene.

Read More
Loading